【简介】博士后招聘网整理分享“英国弗朗西斯·克里克研究所2019年招聘博士后职位”，浏览查询更多博士后招聘计划请访问博士后招聘网。

招聘简介：

职称：博士后培训研究员

地点：伦敦米德兰路弗朗西斯克里克研究所

合同：定期，4年

全职

薪酬：具有竞争优势，受技能和经验的影响

空缺ID：9566

简短的摘要

我们寻求计算生物学方面有才华和积极性的博士后加入Peter Van Loo的癌症基因组学实验室。该职位持有人将在Genomics England的100,000 Genomes项目中进行肉瘤的大规模基因组学分析，描述驱动突变和肉瘤实体突变过程的情况，并研究肉瘤的进化史。

英文原文：

Job title: Postdoctoral Training Fellow

Location: The Francis Crick Institute, Midland Road, London

Contract: Fixed-term, 4 years

Full time

Salary: Competitive with benefits, subject to skills and experience

Vacancy ID: 9566

Short summary

We seek a talented and motivated postdoc in computational biology to join the Cancer Genomics laboratory of Peter Van Loo. The post holder will perform large-scale genomics analyses of sarcomas in the context of Genomics England’s 100,000 Genomes project, characterizing the landscape of driver mutations and mutational processes across sarcoma entities, and studying the evolutionary history of sarcomas.

Project scope

Sarcomas are tumours of mesenchymal origin, encompassing approximately 1% of adult cancers and 15% of childhood cancers. They represent a collection of individually rare cancer types that are often understudied. Through the 100,000 Genomes Project, the UK sarcoma community has collected whole-genome sequences of >1,700 cancer samples from >1,300 sarcoma patients. This now allows us an exciting and unprecedented view into the genomics of these cancers. As part of the Sarcoma GeCIP (Genomics England Clinical Interpretation Partnership), the Cancer Genomics group has taken the lead in the somatic genomics analyses of these data.

This is a highly collaborative project, in which the successful candidate will lead analyses into the drivers, mutational processes and evolution of these sarcomas. The candidate will:

· Collaborate closely with a sarcoma GeCIP core bioinformatician to set up and run pipelines for genomics analyses (alignment, SNV calling, indel calling, SV calling and copy number calling).

· Perform analyses of recurrent SNV, indel and SV drivers across sarcoma entities.

· Perform studies of copy number complexity, chromothripsis, and other mutational processes.

· Study intra-tumour heterogeneity using single-sample and multi-sample (approx. ¼ of the cases) analyses, potentially supplemented with single-cell analyses.

· Perform timing analysis of mutations, copy number changes and punctuated evolutionary processes, and infer timelines of sarcoma evolution.

· Work closely with sarcoma GeCIP leadership (steering committee: Adrienne Flanagan (main sarcoma GeCIP lead), Peter Van Loo, Gareth Bond, Stephan Beck) and other GeCIP members to facilitate complementary and downstream analyses.

About us

The Francis Crick Institute is a biomedical discovery institute dedicated to understanding the fundamental biology underlying health and disease. Its work is helping to understand why disease develops and to translate discoveries into new ways to prevent, diagnose and treat illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases.

An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King’s College London.

The Crick was formed in 2015, and in 2016 it moved into a new state-of-the-art building in central London which brings together 1500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under in one building in Europe.

The Francis Crick Institute will be world-class with a strong national role. Its distinctive vision for excellence includes commitments to collaboration; developing emerging talent and exporting it the rest of the UK; public engagement; and helping turn discoveries into treatments as quickly as possible to improve lives and strengthen the economy.

· If you are interested in applying for this role, please apply via our website.

· The closing date for applications is 23 June 2019 at 23:30.

· All offers of employment are subject to successful security screening and continuous eligibility to work in the United Kingdom.